Stay updated with breaking news from Richard Pops. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility in Athlone, Ireland to...
Alkermes plans to initiate phase 2 trials for its orexin-2 receptor agonist aimed at treating narcolepsy within the first half of the year.
Alkermes plc (NASDAQ:ALKS) Q4 2023 Earnings Call Transcript February 15, 2024 Alkermes plc misses on earnings expectations. Reported EPS is $0.22 EPS, expectations were $0.46. Alkermes plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. And welcome to the […]
Robust Revenue Growth and Strategic Focus Propel Alkermes Into 2024
Pharmaceutical company Alkermes has announced the sale of its research, development and manufacturing plant in County Roscommon to a Danish multinational healthcare company for $92.5m.